GSTM1 and Schnyder corneal dystrophy: HU, a cytotoxic drug, is used in the hope of altering the marrow-proliferation in favour the production of Hb F over Hb S. Evidences suggest usage of HU reduces the incidence of acute pain, rate of acute chest syndrome, blood transfusion and overall mortality among patients with SCD [17, 18].